Homocysteine and carotid plaque stability: A cross- Sectional study in chinese adults

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Yang, Xin ^a   Zhou, Yong ^b   Liu, Chao ^c   Gao, Xiang ^d,e   Wang, Anxin ^b   Guo, Yuming ^f   Li, Wen ^g   Zhao, Xingquan ^b   Liang, Wannian ^a,h  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g HEBEI UNITED UNIVERSITY   (China)

^h Pharmacopoeia Commission of the People's Republic of China   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; AGE; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CAROTID ARTERY DISEASE; CAROTID PLAQUE; CEREBROVASCULAR ACCIDENT; CHINESE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROTIC PLAQUE; BLOOD; CHINA; ECHOGRAPHY; MIDDLE AGED; PATHOLOGY; RISK;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CAROTID ARTERY DISEASES; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS;

EID: 84899692943     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094935     Document Type: Article

References (34)

1. WHO (2004) The Global Burden Of Disease:2004 Update. Switzerland: WHO Press. 11-12P.
2. Yang GH, Wang Y, Zeng YX, George FG, Liang XF et al. (2013) Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. The lancet 381: 1987-2015.
3. Wang YL, Wu D, Liao XL, Zhang W, Zhao XQ, et al. (2007) Burden of stroke in China. Stroke 2: 211-213.
4. Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, et al. (2004) Extracranial Thrombotically Active Carotid Plaque as a Risk Factor for Ischemic. Stroke JAMA 292: 1845-1852.
5. Casscells W, Naghavi M, Janes T, Willerson (2003) Vulnerable Atherosclerotic Plaque A Multifocal Disease. Circulation 107: 2072-2075.
6. Wald DS, Malcolm L, Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325: 1202.
7. Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288: 2015-22.
8. Ralph LS, Kishlay A, Lee HS, Albala BB, Sally S, et al. (2004) Homocysteine and the Risk of Ischemic Stroke in a Triethnic Cohort: The Northern Manhattan Study. Stroke 35: 2263-2269.
9. Giles WH, Macko RF, Amytis T, Daniela M, Bruce O (1999) Homocyst(e)ine and Risk of Cerebral Infarction in a Biracial Population: The Stroke Prevention in Young Women Study. Stroke 30: 1554-1560.
10. Bosts ML, Launer LJ, Lindemans J, Hoes AW, Hofman A, et al.(1999)Homo- )Homocysteine and Short-term Risk of Myocardial Infarction and Stroke in the Elderly: The Rotterdam Study. Arch Intern Med 159: 38-44.
11. Bostom AG, Rosenberg IH, Slibershatz H, Jacques PF, Selhub J, et al. (1999) Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study. Ann Intern Med 131: 352-355.
12. Towfighi A, Markovic D, Ovbiagele B (2010) Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: A nationwide study. Neurological 298: 153-157.
13. Alsulaimani S, Gardener H, Elkind MS, Cheung K, Sacco R, et al. (2013) Elevated Homocysteine and Carotid Plaque Area and Densitometry in the Northern Manhattan Study. Stroke 44: 457-461.
14. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, et al. (2003) From Vulnerable Plaque to Vulnerable Patient A Call for New Definitions and Risk Assessment Strategies. Circulation 108: 1664-1672.
15. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ (2005) Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 46: 937-54.
16. Wang AX, Wu JW, Zhou Y, Guo XH, Luo YX et al. (2013) Measures of Adiposity and Risk of Stroke in China: A Result from the Kailuan Study. PLOS One 17; 8: e61665. doi: 10.1371/journal.pone.0061665.
17. Wang CH, Gao X, Zhou Y, Zhou H, Wang AN et al. (2013) Cardiovascular Health Metrics on the Prevalence of Asymptomatic Intracranial Artery Stenosis: A Cross-Sectional Study. PLoS One 8: e58923. doi: 10.1371/journal.- pone.0058923.
18. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH (1993) Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 39: 1764-79.
19. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG (1995) Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346: 1395-8.
20. Pelisek J, Eckstein HH, Zernecke A (2012) Pathophysiological mechanisms of carotid plaque vulnerability: impact on ischemic stroke. Arch Immunol Ther Exp (Warsz) 60: 431-42.
21. Coppola A, Davi G, De Stefano V, Mancini FP, Cerbone AM, et al. (2000) Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost 26: 243-54.
22. Lentz SR (2005) Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost 3: 1646-54.
23. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, et al. (2001) Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 107: 1263-73.
24. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, et al. (2001) Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 107: 675-83.
25. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, et al. (1994) Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A 91: 6369-73.
26. Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, et al. (1997) Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272: 17012-7.
27. Moat SJ, Bonham JR, Cragg RA, Powers HJ (2000) Elevated plasma homocysteine elicits an increase in antioxidant enzyme activity. Free Radic Res 32: 171-9.
28. Ferretti G, Bacchetti T, Moroni C, Vignini A, Nanetti L, et al. (2004) Effect of homocysteilation of low density lipoproteins on lipid peroxidation of human endothelial cells. J Cell Biochem 2: 351-60.
29. Alsulaimani S, Gardener H, Elkind MS, Cheung K, Sacco RL, et al. (2013) Elevated homocysteine and carotid plaque area and densitometry in the Northern Manhattan Study. Stroke 44: 457-61.
30. Adachi H, Hirai Y, Fujiura Y, Matsuoka H, Satoh A, et al. (2002) Plasma homocysteine levels and atherosclerosis in Japan: epidemiological study by use of carotid ultrasonography. Stroke 33: 2177-81.
31. Kamdi SP, Palkar P (2013) Prevalence of hyperhomocysteinemia in healthy Indian doctors. Bioinformation 9: 193-6.
32. Fukagawa NK, Martin JM, Wurthmann A, Prue AH, Ebenstein D, et al. (2000) Sex-related differences in methionine metabolism and plasma homocysteine concentrations. Am J Clin Nutr 72: 22-9.
33. VITATOPS Trial Study Group (2010) B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol 9: 855-65.
34. Pettigrew LC, Bang H, Chambless LE, Howard VJ, Toole JF (2008) Assessment of pre- and post-methionine load homocysteine for prediction of recurrent stroke and coronary artery disease in the Vitamin Intervention for Stroke Prevention Trial. Atherosclerosis 200: 345-9.